Question: is this a 2) strong advice, 1) weak advice 0) no advice?

Attending conclusive results from ongoing studies, everolimus and exemestane should not be used routinely in male metastatic breast cancer patients, but taking into account for selected cases.
user
This is a strong advice
assistant